Argent Trust CO Abb Vie Inc. Transaction History

Argent Trust CO

$2.39 Billion
Q3 2024

A detailed history of Argent Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Argent Trust CO holds 199,886 shares of ABBV stock, worth $36 Million. This represents 1.65% of its overall portfolio holdings.

Number of Shares

199,886

Previous 204,172 2.1%

Holding current value

$36 Million

Previous $35 Million 12.72%

% of portfolio

1.65%

Previous 1.56%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $702,218 - $854,328	-4,286 Reduced 2.1%	199,886 $39.5 Million
Q2 2024 Aug 12, 2024	BUY	$154.79 - $180.76 $291,314 - $340,190	1,882 Added 0.93%	204,172 $35 Million
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $516,698 - $588,729	3,233 Added 1.62%	202,290 $36.8 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $295,702 - $333,030	2,149 Added 1.09%	199,057 $30.8 Million
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $96,451 - $111,657	722 Added 0.37%	196,908 $29.4 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $1.55 Million - $1.92 Million	11,661 Added 6.32%	196,186 $26.4 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $686,463 - $790,565	4,747 Added 2.64%	184,525 $29.4 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $119,499 - $143,311	-864 Reduced 0.48%	179,778 $29.1 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $582,337 - $667,902	4,339 Added 2.46%	180,642 $24.2 Million
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $89,040 - $113,199	647 Added 0.37%	176,303 $27 Million
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $107,827 - $133,783	-817 Reduced 0.46%	175,656 $28.5 Million
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $136,113 - $172,223	1,267 Added 0.72%	176,473 $23.9 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $589,349 - $669,000	5,539 Added 3.26%	175,206 $18.9 Million
Q2 2021 Aug 09, 2021	BUY	$105.21 - $117.21 $3.07 Million - $3.42 Million	29,182 Added 20.77%	169,667 $19.1 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $524,492 - $577,402	5,127 Added 3.79%	140,485 $15.2 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $306,747 - $414,141	3,811 Added 2.9%	135,358 $14.5 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $307,815 - $361,273	3,583 Added 2.8%	131,547 $11.5 Million
Q2 2020 Aug 04, 2020	BUY	$73.37 - $98.18 $1.08 Million - $1.44 Million	14,700 Added 12.98%	127,964 $12.6 Million
Q1 2020 May 11, 2020	SELL	$64.5 - $97.79 $174,666 - $264,815	-2,708 Reduced 2.34%	113,264 $8.63 Million
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $106,608 - $133,389	1,478 Added 1.29%	115,972 $10.3 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $300,540 - $361,335	4,772 Added 4.35%	114,494 $8.67 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $71,875 - $91,874	1,094 Added 1.01%	109,722 $7.98 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $247,079 - $290,800	3,203 Added 3.04%	108,628 $8.76 Million
Q4 2018 Feb 06, 2019	BUY	$77.85 - $96.01 $364,493 - $449,518	4,682 Added 4.65%	105,425 $9.72 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $487,582 - $542,038	5,484 Added 5.76%	100,743 $9.46 Million
Q2 2018 Apr 15, 2019	BUY	$89.78 - $106.23 $73,888 - $87,427	823 Added 0.87%	95,259 $8.82 Million
Q2 2018 Aug 15, 2018	BUY	$89.78 - $106.23 $4.78 Million - $5.66 Million	53,241 Added 129.24%	94,436 $8.75 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $2.24 Million - $2.99 Million	24,302 Added 143.86%	41,195 $3.9 Million
Q4 2017 Feb 12, 2018	SELL	$89.56 - $98.21 $1.03 Million - $1.13 Million	-11,472 Reduced 40.44%	16,893 $1.63 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $1.98 Million - $2.53 Million	28,365	28,365 $2.52 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Argent Trust CO with notifications on news.

Account